EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity

Xiaolong Xu, Youbin Ding, Yafang Dong, Haitao Yuan, Peng Xia, Chengming Qu, Jingbo Ma, Huifang Wang, Xiaodong Zhang, Liang Zhao, Zhijie Li iD, Zhen Liang und 1 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202401905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Xiaolong Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics and Shenzhen Clinical Research Centre for Geriatrics, Department of Urology, Shenzhen People's Hospital (The First Affiliate…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences, Science and Technology Foundation of Shenzhen, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteria can be utilized for cancer therapy owing to their preferential colonization at tumor sites. However, unmodified non‐pathogenic bacteria carry potential risks due to their non‐specific targeting effects, and their anti‐tumor activity is limited when used as monotherapy. In this study, a biohybrid‐engineered bacterial system comprising non‐pathogenic MG1655 bacteria modified with CDH17 nanobodies on their surface and conjugated with photosensitizer croconium (CR) molecules is developed. The resultant biohybrid bacteria can efficiently home to CDH17‐positive tumors, including gastric, pancreatic, and colorectal cancers, and significantly suppress tumor growth upon irradiation. More importantly, biohybrid bacteria‐mediated photothermal therapy (PTT) induced abundant macrophage infiltration in a syngeneic murine colorectal model. Further, that the STING pathway is activated in tumor macrophages by the released bacterial nucleic acid after PTT is revealed, leading to the production of type I interferons. The addition of CD47 nanobody but not PD‐1 antibody to the PTT regimen can eradicate the tumors and extend survival. This results indicate that bacteria endowed with tumor‐specific selectivity and coupled with photothermal payloads can serve as an innovative strategy for low‐immunogenicity cancers. This strategy can potentially reprogram the tumor microenvironment by inducing macrophage infiltration and enhancing the efficacy of immunotherapy targeting macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesGastrointestinal NeoplasmsAnimalsMiceDisease Models, AnimalMembrane ProteinsPhotothermal TherapyCell Line, TumorPhotosensitizing AgentsHumansSTING Protein

Stichwörter der Autor:innen

STINGbacteriaimmunotherapynanobodyphotothermal therapy

Substanzen

Single-Domain AntibodiesMembrane ProteinsPhotosensitizing AgentsSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Department of Geriatrics and Shenzhen Clinical Research Centre for Geriatrics, Department of Urology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second…
  • Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou, 510632, China.
  • Department of Medical Imaging, The Third Affiliated Hospital, Southern Medical University (Academy of Orthopedics Guangdong Province), Guangzhou, 510515, China.
  • Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
  • Department of Pathology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, 528308, China.
  • Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.

ORCID-Profile: Zhijie Li

Förderung

  • Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences
  • Science and Technology Foundation of Shenzhen
  • National Key Research and Development Program of China
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • CACMS Innovation Fund
  • Shenzhen Medical Research Fund
  • Distinguished Expert Project of Sichuan Province Tianfu Scholar
  • Fundamental Research Funds for the Central public welfare research institutes

Zitieren

APA

Xu, X., Ding, Y., Dong, Y., Yuan, H., Xia, P., Qu, C., Ma, J., Wang, H., Zhang, X., Zhao, L., Li, Z., Liang, Z., & Wang, J. (2024). Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity. Advanced Science. https://doi.org/10.1002/advs.202401905

Vancouver

Xu X, Ding Y, Dong Y, Yuan H, Xia P, Qu C, et al. Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity. Advanced Science. 2024. doi:10.1002/advs.202401905

BibTeX
@article{Xu2024,
  author = {Xu, Xiaolong and Ding, Youbin and Dong, Yafang and Yuan, Haitao and Xia, Peng and Qu, Chengming and Ma, Jingbo and Wang, Huifang and Zhang, Xiaodong and Zhao, Liang and Li, Zhijie and Liang, Zhen and Wang, Jigang},
  title = {Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202401905}
}
Kostenlos starten →